PNC Financial Services Group’s Tarsus Pharmaceuticals TARS Stock Holding History

PNC Financial Services Group’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.3K	Sell	482 -228	-32%	-$14.6K	﹤0.01%	3586
2026 Q1	$49.8K	Buy	710 +558	+367%	+$39K	﹤0.01%	3222
2025 Q4	$12.4K	Sell	152 -286	-65%	-$21.4K	﹤0.01%	3863
2025 Q3	$26K	Buy	438 +311	+245%	+$15.3K	﹤0.01%	3527
2025 Q2	$5.14K	Sell	127 -81	-39%	-$3.65K	﹤0.01%	4121
2025 Q1	$10.7K	Sell	208 -2	-1%	-$99	﹤0.01%	3806
2024 Q4	$11.6K	Buy	210 +30	+17%	+$1.36K	﹤0.01%	3743
2024 Q3	$5.92K	Buy	180 +13	+8%	+$365	﹤0.01%	3989
2024 Q2	$4.54K	Sell	167 -11	-6%	-$370	﹤0.01%	4018
2024 Q1	$6.47K	Buy	178 +173	+3,460%	+$5.09K	﹤0.01%	3886
2023 Q4	$101	Buy	+5	New	+$83	﹤0.01%	4520

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PNC Financial Services Group's TARS Position: Q2 2026 in Review

PNC Financial Services Group reduced its Tarsus Pharmaceuticals (TARS) stake by 32% in Q2 2026, selling an estimated $14.6K and leaving 482 shares worth $30.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3586.

PNC Financial Services Group first reported a position in TARS in Q4 2023 and has held it in 11 quarters since. The position peaked at $49.8K in Q1 2026. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

PNC Financial Services Group held 482 shares of Tarsus Pharmaceuticals worth $30.3K as of Q2 2026.
PNC Financial Services Group sold 228 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $14.6K.
Tarsus Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3586 holding.
PNC Financial Services Group first reported a position in Tarsus Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
PNC Financial Services Group's Tarsus Pharmaceuticals position peaked at $49.8K in Q1 2026.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.